United States · FDA National Drug Code directory
regadenoson
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 36000-364_af34327b-48b9-4544-b9ef-4685a261a71e
- Product NDC
- 36000-364
- Form
- INJECTION, SOLUTION
- Composition / generic term
- regadenoson
- Labeler
- Baxter Healthcare Corporation
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230523
- Source listing expiry
- 20271231
Source-listed ingredients
- REGADENOSON — .08 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, PLASTIC in 1 CARTON (36000-364-01) / 5 mL in 1 SYRINGE, PLASTIC · 36000-364-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →